HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisa R Hartman Selected Research

Dalteparin (Dalteparin Sodium)

1/2022A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venous thromboembolism treatment in children with and without cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisa R Hartman Research Topics

Disease

1Hemorrhage
01/2022
1Neoplasms (Cancer)
01/2022
1Venous Thromboembolism
01/2022

Drug/Important Bio-Agent (IBA)

1Dalteparin (Dalteparin Sodium)FDA Link
01/2022